Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sebi deploys AI tool 'Sudarshan', removes 1.2 lakh misleading 'finfluencer' posts: Tuhin Kanta Pandey
The Securities and Exchange Board of India has removed over 1.2 lakh misleading posts by unregistered financial influencers. Using an AI tool named Sudarshan, Sebi tracks violations in the digital space. The regulator is also warning retail investors about the high risks of options trading, noting that most lose money. SEBI emphasizes a calibrated approach to market development.
AI, consumption trends put Vishal Mega Mart, MTAR Tech and IT stocks in focus: Siddhartha Khemka
Siddhartha Khemka of Motilal Oswal Financial Services highlights three parallel themes shaping markets: recovery in consumption-led retail, rising demand linked to AI infrastructure buildout, and structural changes within IT services driven by artificial intelligence adoption. While volatility may persist in the near term, sector-specific opportunities continue to emerge across retail, engineering and technology companies.
IRFC shares in focus as government won’t exercise greenshoe option in OFS; retail participation opens today
IRFC shares are in focus after the government chose not to exercise the greenshoe option in its OFS amid undersubscription from institutional investors. While retail bidding opens today, the PSU continues to report steady financial performance, with record quarterly profit and improving margins despite a marginal dip in revenue.
First Tick: Top global cues to watch in today's trade
Here is how financial markets across the globe fared overnight.
Buy Dr Lal Pathlabs; target of Rs 1740: Emkay Global Financial
Emkay Global Financial is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 1740 in its research report dated Jun 09, 2026.